Price target
1196.560.00 0.00%
The 25 analysts offering 1 year price forecasts for AUROPHARMA have a max estimate of — and a min estimate of —.
Analyst rating
Based on 25 analysts giving stock ratings to AUROPHARMA in the past 3 months.
EPS
0.00
Reported
Estimate
Reported
Estimate
Surprise
Revenue
0.00
Reported
Estimate
Reported
Estimate
Surprise
This info isn't a recommendation for what you should personally do, so please don't take the data as investment advice. As with any trade, always look first, then leap. Read more in the Terms of Use.
Frequently Asked Questions
AUROPHARMA EPS for the last quarter is 16.04 INR despite the estimation of 15.39 INR. In the next quarter EPS is expected to reach 15.15 INR. Track more of AUROBINDO PHARMA financials and stay on top of what is up with the company.
In the next quarter AUROBINDO PHARMA revenue is expected to reach 73.27 B INR. Check out AUROBINDO PHARMA revenue and earnings and make informed decisions.
According to analysts, AUROPHARMA price target is 1196.56 INR with a max estimate of 1400.00 INR and a min estimate of 980.00 INR. Check if this forecast comes true in a year, meanwhile keep track of the current situation with AUROPHARMA news and stock market news.
We've gathered opinions of 25 analysts rating AUROPHARMA stock in the past 3 months. Most of them backed up the strong buy trend, and after taking into account other opinions, the overall rating was calculated as buy. Note that it's not a trading advice — your own analysis is still required.